News
StockStory.org on MSN20h
Gilead Sciences’s Q2 Earnings Call: Our Top 5 Analyst Questions
Gilead Sciences delivered a better-than-expected second quarter, propelled by the strong performance of its HIV portfolio and ...
6d
Pharmaceutical Technology on MSNGilead’s Yeztugo sales “ahead of expectations” following launch
Gilead's PrEP Yeztugo is set to become the pharma's star asset, with GlobalData forecasting of just under $5bn in 2031.
2d
The Herald on MSNYeztugo: Life-saving HIV prevention injection costs $28,000 a year
Gilead Sciences has secured approval from the United States health authorities for its new HIV prevention injection, Yeztugo, but concerns are growing over its steep price tag.
Noticed YouTube's background changing colors while you watch? That's Ambient Mode and you can turn it off if it's not your ...
"Even without requesting ID, why is an AI combing through every single video I watch?" Gerfdas posited. "As an adult, I ...
Por MICHAEL LIEDTKEYouTube comenzará a probar el miércoles un nuevo sistema de verificación de edad en Estados Unidos que se ...
2d
FOX 2 Detroit on MSNYouTube, others may ask for your ID as online safety laws sprout across the globe
Some users of YouTube in the United States may be barred from the platform starting Wednesday as the Google-owned media giant ...
YouTube is launching a new AI-powered age verification system in the U.S. that estimates users’ ages by verifying their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results